KRAS Allelic Imbalance: Strengths and Weaknesses in Numbers. (2017)
Attributed to:
Core-Modelling tumour development and therapy
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.molmed.2017.03.005
PubMed Identifier: 28372922
Publication URI: http://europepmc.org/abstract/MED/28372922
Type: Journal Article/Review
Volume: 23
Parent Publication: Trends in molecular medicine
Issue: 5
ISSN: 1471-4914